Skip to content

Clinical trials

Completed Neoplasm Metastasis trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Completed Country / region: Japan Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20072
20083
20094
20102
20114
20128
20139
20144
20157
20163
20176
20184
20191
20214

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed66

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
Eli Lilly and Company8
Pfizer6
Novartis Pharmaceuticals5
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan4
AbbVie2
Bayer2
EMD Serono Research & Development Institute, Inc.2
Japan Clinical Oncology Group2
AO Innovation Translation Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis66
Neoplasms19
Breast Neoplasms12
Carcinoma, Non-Small-Cell Lung7
Colorectal Neoplasms5
Melanoma5
Stomach Neoplasms4
Carcinoma, Renal Cell3
Lung Neoplasms3
Prostatic Neoplasms3

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.